AmbioPharm - A Global Peptide CDMO Information

Summary

AmbioPharm - A Global Peptide CDMO is a private company that has been in the industry for 19 years. The company currently specializes in the Pharmaceuticals, Biotechnology areas. The position of the President & CEO is occupied by Chris J. Bai. Its headquarters is located at North Augusta, South Carolina, USA. The number of employees ranges from 500 to 1.0K. The annual revenue of AmbioPharm - A Global Peptide CDMO varies between 25M and 100M. To connect with AmbioPharm - A Global Peptide CDMO employee register on SignalHire.

Organization Website	ambiopharm.com
Social Links
Phone Number	803-442-7590, (415) 921-3593
Industries	Pharma
Headquarters Location	1024 Dittman Court, North Augusta, SC, 29842 US
Employees Size	500-1000 employees
Specialties	NCEs, Cosmetic Peptides, GMP Peptides, Peptides, Custom Peptide Synthesis, Peptide Active Pharmaceutical Ingredients (APIs), NCE peptides, Preclinical Manufacturing, Process Development, Analytical Methods Support, Regulatory Support, Commercial Peptide Manufacturing, GMP Peptide Manufacturing, Peptide Contract Development & Manufacturing Organization (CDMO), Clinical Peptides, Agricultural peptides, Peptide API Manufacturing, Clinical Grade Peptide Manufacturing, Peptide Manufacturing, FDA Inspected
SIC Code	2836
DMA Code	Augusta Metropolitan Area
Founded	2005
Estimated Annual Revenue	$25M - 100M
Operating Status	Independent Company